News from the Cancer Centers: Exploring Immunotherapy and Pancreatic Cancer
A recent blog post by the Sidney Kimmel Cancer Center – Jefferson Health examined whether the power of immunotherapy...
A recent blog post by the Sidney Kimmel Cancer Center – Jefferson Health examined whether the power of immunotherapy...
Pancreatic cancer is a deadly disease with a five-year survival rate of a mere 8.2 percent, according to statistics...
Philadelphia Eagles player Rodney McLeod he has looked to honor his grandmother’s memory by supporting the American Association for...
Party With a Purpose will honor Penn surgeon Jeffrey Drebin and will donate funds from its gala to the...
This week, scientists from around the world will convene in Orlando, Florida, as the AACR hosts a conference titled...
Yesterday, Onivyde, which is a nanotherapeutic form of the conventional chemotherapeutic irinotecan, was approved by the U.S. Food and...
Eric R. Lutz, PhD, a recipient of the Pancreatic Cancer Action Network-AACR Career Development Award, studies the development of...
Costas Lyssiotis, PhD, a 2013 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant recipient, is conducting research to understand...
The public craves solid health information, and knowledge about cancer research and treatment is vital to their well-being. The...
Philadelphia Inquirer senior health reporter Marie McCullough describes the challenge of pancreatic cancer and the efforts underway by the...